Translate   10 w

https://www.selleckchem.com/products/FTY720.html
justed RR was 0·58 (95% CI 0·47-0·71) for venous thromboembolism, 1·27 (0·92-1·74) for major bleeding, and 1·34 (1·19-1·51) for minor bleeding. Prespecified subgroup analysis of venous thromboembolism occurrence by cancer type identified the most certain benefit from heparin treatment in patients with lung cancer (RR 0·59 [95% CI 0·42-0·81]), which dominated the overall reduction in venous thromboembolism. Certainty of the evidence for the outcomes ranged from moderate to high. Low-molecular-weight heparin reduces risk of venous thromboe

  • Like
  • Love
  • HaHa
  • WoW
  • Sad
  • Angry